CTD-MT 6.25/50/40 Tablet ER

Overview CTD-MT 6.25/50/40 Tablet ER

Hypertensive patients may benefit from the extended-release combination medication, CTD-MT 6.25/50/40 Tablet ER. This treatment lowers blood pressure by promoting vascular relaxation and enhancing cardiac efficiency. It also facilitates diuresis, eliminating excess fluid and electrolytes. Administer this medication at the same time each day, with or without food, for optimal efficacy. Due to its diuretic action, consider daytime dosing, at least four hours before sleep, to minimize nocturnal urination. Dosage and frequency are determined by your physician, based on your individual needs and response. Continuous use, as directed, is crucial for sustained blood pressure control. Commonly reported side effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular monitoring of renal function and electrolyte levels is essential. For optimal outcomes, combine this medication with lifestyle modifications such as a balanced diet, regular physical activity, and smoking cessation. Increased fluid intake may help manage potential dryness of the mouth or thirst. Inform your physician of any existing circulatory issues, liver or kidney disease, or pregnancy before initiating treatment. Complete disclosure of all other medications is necessary to avoid potential drug interactions or compromised efficacy.

Primary Ingredients of CTD-MT 6.25/50/40 Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of CTD-MT 6.25/50/40 Tablet ER

Elevated blood pressure

Major Benefits of CTD-MT 6.25/50/40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. CTD-MT 6.25/50/40 Extended-Release tablets can be ingested with or without food, though consistent timing is recommended.

Common Side effects of CTD-MT 6.25/50/40 Tablet ER:

• Nausea
• Taste change
• Diarrhea
• Upset stomach
• Headache
• Dizziness
• Weakness
• Cold extremities
• Numbness of extremity
• Increased uric acid level in blood
• Increased blood lipid level
• Decreased magnesium level in blood
• Slow heart rate
• Decreased sodium level in blood
• Decreased blood pressure

How to use CTD-MT 6.25/50/40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-MT 6.25/50/40 Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent daily timing is recommended.

How CTD-MT 6.25/50/40 Tablet ER works:

The extended-release tablet CTD-MT 6.25/50/40 mg combines chlorthalidone, metoprolol succinate, and telmisartan to achieve effective blood pressure reduction.

What if you forget to take CTD-MT 6.25/50/40 Tablet ER :

Should you forget a CTD-MT 6.25/50/40 Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.